These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10794952)

  • 1. Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation.
    AliAbadi FS; Lees P
    Int J Antimicrob Agents; 2000 May; 14(4):307-13. PubMed ID: 10794952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.
    Schentag JJ
    J Chemother; 1999 Dec; 11(6):426-39. PubMed ID: 10678784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA; Sanchez Bruni SF; Jones DG
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of marbofloxacin in horses.
    Bousquet-Melou A; Bernard S; Schneider M; Toutain PL
    Equine Vet J; 2002 Jul; 34(4):366-72. PubMed ID: 12117108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.
    Li RC; Zhu M; Schentag JJ
    Clin Pharmacokinet; 1999 Jul; 37(1):1-16. PubMed ID: 10451780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of fluoroquinolones.
    Lode H; Borner K; Koeppe P
    Clin Infect Dis; 1998 Jul; 27(1):33-9. PubMed ID: 9675446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: In vitro and animal models.
    Schentag JJ; Meagher AK; Forrest A
    Ann Pharmacother; 2003 Sep; 37(9):1287-98. PubMed ID: 12921513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance.
    Cazzola M; Matera MG; Noschese P
    Pulm Pharmacol Ther; 2000; 13(6):249-56. PubMed ID: 11061979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pharmacokinetics and pharmacodynamics: does the dose matter?
    MacGowan AP
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S238-9. PubMed ID: 11524725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolides: pharmacokinetics and pharmacodynamics.
    Van Bambeke F; Tulkens PM
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S17-23. PubMed ID: 11574190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational dosing of antimicrobial drugs: animals versus humans.
    Lees P; Shojaee Aliabadi F
    Int J Antimicrob Agents; 2002 Apr; 19(4):269-84. PubMed ID: 11978498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.
    Slavik RS; Jewesson PJ
    Clin Pharmacokinet; 2003; 42(9):793-817. PubMed ID: 12882587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pharmacokinetics on the bactericidal activity of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae and the emergence of resistance.
    Thorburn CE; Edwards DI
    J Antimicrob Chemother; 2001 Jul; 48(1):15-22. PubMed ID: 11418508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do we really know about antibiotic pharmacodynamics?
    Gunderson BW; Ross GH; Ibrahim KH; Rotschafer JC
    Pharmacotherapy; 2001 Nov; 21(11 Pt 2):302S-318S. PubMed ID: 11714222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.
    Ramalingam B; Sidhu PK; Kaur G; Venkatachalam D; Rampal S
    J Vet Pharmacol Ther; 2015 Dec; 38(6):529-36. PubMed ID: 25776301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New pharmacodynamic parameters for antimicrobial agents.
    Li RC
    Int J Antimicrob Agents; 2000 Feb; 13(4):229-35. PubMed ID: 10755236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens.
    Craig W
    Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S6-8. PubMed ID: 8477766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.